Welcome aboard.
Four quick questions so the Monday digest reads as relevant, not generic. Skip any of them. We never share your answers, and you can opt out of every email at the bottom of every send.
What we use this for: we segment the Monday digest so semaglutide patients see semaglutide updates, Aetna patients see Aetna prior-authorization changes, and so on. Your answers stay on our side. We never sell email addresses. We do not share answers with any program in our chart.
Research panel (optional): later in the survey we ask if you want to join our patient panel. That is a separate opt-in. The Monday digest works without it.